DELRAY BEACH, Fla., May 17, 2017 /PRNewswire-USNewswire/ -- The Sperling Medical Group announces the first successful noninvasive outpatient treatment for Essential Tremor in Florida. On May 12, two tremor patients underwent MRI-guided Focused Ultrasound (MRgFUS) using the Neuravive™ system, establishing the Sperling Medical Group as the first U.S. site to treat two patients on the same day. Immediate symptom improvement for both patients ranged from 70-95%.
Essential Tremor (ET) is the most common movement disorder. It is usually hereditary. While non-life threatening, it can be severely disabling. Medication may help initially, but becomes less effective as tremors worsen. Eventually, tasks like eating or dressing can become impossible. Surgery may help but has associated risks. The Sperling Medical Group now offers FDA-approved Neuravive™ to stop tremors at their source in the center of the brain. Under real-time MRI guidance, the problem area is identified, then ultrasound waves are focused on the target. The waves pass harmlessly through healthy brain tissue, meeting accurately to destroy the target. There are no probes, surgery or brain implants, and results are immediate.
One patient, Sheila, age 66, described her treatment results. "I think the experience was wonderful, it was life changing for me, I have a 95% improvement in my hand." Regarding the Group's professionalism, she emphasized, "I have worked in the medical field for 25 years and have never met a neurosurgeon and his staff who were so warm and dedicated to the patient. They took the time to explain and talk me through the entire procedure."
Dr. Dan Sperling, the Group's Medical Director, notes that his Group is the only Southeast treatment center offering Neuravive™. He states, "MRgFUS revolutionizes ET treatment. It improves quality of life by restoring control of the affected hand." Dr. Travis Tierney, the Group's Harvard-trained Neurosurgery Director, says that doing two treatments in a day "indicates the routine nature of the procedure, and the ease of flow within our practice."
Besides Neuravive™ for ET, the Group provides other outpatient MRgFUS treatments for facet joint pain, metastatic bone cancer, and uterine fibroids. Also, under international prostate cancer expert Dr. Sperling, the Group is a participating site for a MRgFUS focal prostate cancer clinical study. All procedures are performed under the guidance of their powerful, state-of-the-art magnet. Benefits include no infection risk, very rapid recovery, and high rates of durable success. Their clinical team brings top experience and compassion to diagnosing and healing patients. Dr. Sperling and his Group strive for excellent post-treatment quality of life for each patient.
About Sperling Medical Group
Sperling Medical Group is a state-of-the-art center offering advanced 3T MRI-based detection, diagnosis and minimal-to-noninvasive treatments for a variety of disease conditions. The Group is located at 4205 W. Atlantic Ave, Bldg. D, Delray Beach, FL 33445. Learn more at www.sperlingmedicalgroup.com.
SOURCE Sperling Medical Group